Rite Aid (RAD) Misses Q4 EPS by $1.07, Revenue Beats Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
- Marvell agrees to acquire Lumentum in all-stock deal valued at $115B
- Cipher Digital posts Q3 revenue of $27M, logs first HPC lease income
- Binance sees spike in withdrawals as exchange returns online after $6.3 billion heist
- Marvell to buy Lumentum in $115 billion deal in AI data-center bet
- Iran, Qatari mediators hold third day of talks to end US-Iran war
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Rite Aid Corporation Reports Strong Fiscal 2022 Fourth Quarter and Full Year Results and Provides Fiscal 2023 Outlook
April 14, 2022 7:00 AM EDTFull Year Revenues Increased $525 million to $24.6 billion; Pharmacy Sales Increased 12% Full Year Net Loss per Share Increased from $1.87 to $9.96 Driven by Non-Cash Impairment Charges Full Year Adjusted EBITDA Increased 16% to $505.9 million Driven by Strong Retail Pharmacy Performance Generated $379 million in Operating Cash Flow and Reduced Net Debt by $212 million Leverage Ratio Improved Year Over Year from 6.7 to 5.4 Times Issues Fiscal 2023 Adjusted EBITDA Outlook in Range of $460 million to $500 million Announces Cost Rationalization Program that Targets $170 million in Savings
PHILADELPHIA--(BUSINESS WIRE)-- Rite Aid... More



